We also observed that mice mutant in toll-like receptor 4 (C3H/HeJ) did not develop ARDS following LPS exposure and did not develop Th17 (IL-17a+IL-22− and IL-17a+IL-22+) cells (Fig. 4E–H). This evidence concerns the gene IL22 and acute respiratory distress syndrome.